Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Mupirocin 2% nasal ointment |
| BNF code | 1202030R0AAAAAA |
| Virtual Therapeutic Moiety | Mupirocin |
| Date identifier became valid | 2 Jun 2023 |
| Previous product identifier | 331140000 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Mupirocin calcium |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 387397004 |
| Strength value numerator | 20.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | ointment.nasal |
| Dose Form | |
| Formulation | Nasal ointment |
| Drug Route | |
| Route | Nasal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Bactroban 2% nasal ointment (GlaxoSmithKline UK Ltd) | |
| Bactroban 2% nasal ointment (Sigma Pharmaceuticals Plc) | |
| Bactroban 2% nasal ointment (Stephar (U.K.) Ltd) | |
| Mupirocin 2% nasal ointment (Tetris Pharma Ltd) | |
| Virtual Medicinal Product Packs | |
| Mupirocin 2% nasal ointment 3 gram | |
| Mupirocin 2% nasal ointment 5 gram | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.